DEVELOPMENT AND VALIDATION OF NEW STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ELBASVIR AND GRAZOPREVIR IN BULK AND PHARMACEUTICAL DOSAGE FORM
Journal: Indian Drugs (Vol.57, No. 09)Publication Date: 2020-09-28
Authors : Dandu Girija; Basu Venkateswara Reddy;
Page : 53-59
Keywords : * For correspondence E-mail: girija.dandu@gmail.com;
Abstract
The present study describes the development and validation of a new stability indicating RP-HPLC method for simultaneous estimation of elbasvir and grazoprevir in bulk and pharmaceutical dosage form. The chromatographic separation was done by using reverse phase YMC column (4.6 x 250mm, 5μm).The mobile phase used was mixture of HPLC grade water acetonitrile (70:30V/V) at flow rate of 1ml/ min in isocratic mode and detection was carried out using PDA detector at 244nm.The developed method showed a good linearity in the range of 100-500μg/mL for elbasvir and 200-1000 μg/mL for grazoprevir with regression co-efficient of 0.999 for both the drugs. The % recovery of drugs was found to be 100.1% for elbasvir and 100.38% for grazoprevir. The proposed stability indicating method was accurate, precise, robust, stable and specific. The developed method was validated in accordance with ICH guidelines.
Other Latest Articles
- EVALUATION OF ANTIBACTERIAL POTENTIAL OF EXTRACTS OF MOCHARAS (GUM OF BOMBAX MALABARICUM) AGAINST CERTAIN BACTERIAL STRAINS
- SYNTHESIS, CHARACTERIZATION AND SKELETAL MUSCLE RELAXANT ACTIVITY FOR NOVEL [1,4]DIAZEPINO[2,3-G]QUINOXALINE DERIVATIVES
- SYNTHESIS, BIOLOGICAL EVALUATION AND DOCKING STUDIES OF NON HEPATOTOXIC 5-SUBSTITUTED THIAZOLIDINE-2, 4-DIONES AS ANTIDIABETIC, ANTI-HYPERLIPIDEMIC, ANTI-OXIDANT AND CYTOTOXIC AGENTS
- INTRUSION OF GLYCOGEN SYNTHASE KINASE-3Β TO COPE VARIOUS CARDIAC DISORDERS AT MOLECULAR LEVEL
- NEED FOR REGULATORY AFFAIRS PERSONNEL DEVELOPMENT
Last modified: 2020-11-10 14:30:32